Riskpilot← Back to searchSign inGet full accessRonéus Frisk AB
ABActiveOrg 5591805709Sjöviksvägen 2General medical practice activities · NACE 8621Est. 20182 employees
Revenue 2025
SEK 85K
-25% vs 2024
EBITDA margin
63.9%
+125% vs 2024
Equity ratio
83.4%
Financial strength
Net profit 2025
SEK 54K
+288% vs 2024
| Revenue | SEK 85K | -25% |
| EBITDA | SEK 54K | +125% |
| Net profit | SEK 54K | +288% |
| Total assets | SEK 144K | +47% |
| Equity | SEK 120K | +84% |
| Employees | 2 | — |
Legal name
Ronéus Frisk AB
Org number
5591805709
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
19 november 2018
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva konsultverksamhet, undervisning och forskning inom hälso- och sjukvård, primärvård, ortopedi, öron näsa hals, estetisk medicin, idrotts- och expeditionsmedicin samt därmed förenlig verksamhet. Bolaget kommer vara verksamt med handel och förvaltning av fastigheter, uthyrning av fastigheter, förvaltning av värdepapper samt därmed förenlig verksamhet.
Address
Sjöviksvägen 2
Email
carl@roneusmail.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 42 | 57 | 155 | 113 | 85 |
| Staff expenses | — | −19 | −24 | — | −0 |
| EBITDA | −89 | −61 | 13 | 24 | 54 |
| Depreciation & amort. | −12 | −13 | −13 | −10 | −0 |
| EBIT | −101 | −74 | 0 | 14 | 54 |
| Net financials | — | 0 | 1 | 1 | 0 |
| Profit before tax | −101 | −74 | 1 | 14 | 54 |
| Tax | −0 | — | — | −0 | — |
| Net profit | −101 | −74 | 1 | 14 | 54 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 185 | 113 | 117 | 98 | 144 |
| Equity | 162 | 88 | 51 | 65 | 120 |
| Long-term debt | 0 | — | — | 0 | — |
| Short-term debt | 23 | 25 | 66 | 33 | 24 |
| Total debt | 23 | 25 | 66 | 33 | 24 |
EBITDA margin
63.9%
This company
15.8%
Market median
+304% vs market
20212025
Equity ratio
83.4%
This company
38.2%
Market median
+118% vs market
20212025
Return on equity
45.4%
This company
18.4%
Market median
+147% vs market
20212025
Net profit margin
64.2%
This company
8.1%
Market median
+693% vs market
20212025
Asset turnover
0.59×
This company
1.12×
Market median
-47% vs market
20212025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CN Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ronéus Frisk AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Nils Ronéus Frisk | Chief Executive Officer | 0 companies |
| Fanny Anna Ronéus Frisk | Chairman | 0 companies |
| Merike Ronéus | Deputy Board Member | 0 companies |
| Per Frisk | Deputy Board Member | 0 companies |